Cardium Therapeutics Interest Expense:
0.0021M for Dec. 31, 2012Cardium Therapeutics Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.0021M |
| Sept. 30, 2012 | 0.00 |
| June 30, 2012 | 0.0007M |
| March 31, 2012 | 0.0014M |
| Dec. 31, 2011 | 0.0011M |
| Sept. 30, 2011 | 0.0004M |
| June 30, 2011 | 0.0014M |
| March 31, 2011 | 0.0026M |
| Dec. 31, 2010 | 0.0006M |
| Sept. 30, 2010 | 0.0002M |
| June 30, 2010 | 0.0007M |
| March 31, 2010 | 0.0014M |
| Dec. 31, 2009 | 0.451M |
| Sept. 30, 2009 | 1.338M |
| June 30, 2009 | 2.972M |
| March 31, 2009 | 1.578M |
| Dec. 31, 2008 | 0.00 |
| Sept. 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
| June 30, 2000 | Go Pro |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
CXM Interest Expense Benchmarks
| Companies | |
|---|---|
| Immunomedics | 0.00 |
| Sangamo BioSciences | 0.00 |
| Strategic Diagnostics | 0.003M |
CXM Interest Expense Rankings
| Overall |
71st percentile 2298 of 8002 |
| Sector |
62nd percentile 259 of 684 in Healthcare |
| Industry |
55th percentile 110 of 248 in Biotechnology |
CXM Interest Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2008 |
| Maximum | 2.972M | Jun 2009 |
| Average | 0.3343M |
